Search

everythinglearnresearchcommunity

for

Search:↓

A new model uses specific blood markers to predict if children's hair loss will return.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

Alopecia areata causes significant stigma and emotional distress, with many affected individuals not receiving adequate support or treatment.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.

Beard alopecia areata causes patchy beard hair loss, often treatable with janus kinase inhibitors.

Alopecia areata patients have higher osteopontin levels and more eye changes, but their vision remains unaffected.

8-OHdG may help diagnose and assess alopecia areata.

Alopecia areata treatments should be personalized, using options like steroids, JAK inhibitors, and other therapies based on individual needs.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Alopecia areata significantly affects mental health and quality of life, with many feeling stigma and few receiving adequate treatment.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Alopecia areata patients have lower SOX9 and CD34 levels, affecting hair growth.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Certain gene variations and low adiponectin levels may increase the risk of hair loss in Egyptians.

Alopecia areata may lead to hearing loss.

People with alopecia areata in German-speaking countries spend a lot on their condition, with hair products and treatments being the most costly.

Low serum ferritin levels are linked to more severe and longer-lasting alopecia areata in children.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Candida antigen is an effective and promising treatment for alopecia areata.